Table 1.
Lifetime and 12-month prevalence of DSM-IV/CIDI MDD along with the proportions of respondents with lifetime and 12-month MDD who have comorbid DSM-IV/CIDI anxiety disordersa in the WHO WMH Surveys
| Lifetime MDD | 12-Month MDD | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lifetime MDD | Lifetime anxiety/ Lifetime MDD | 12-month MDD | Lifetime anxiety/12-month MDD | 12-month anxiety/12-month MDD | |||||||
| % | (s.e.) | % | (s.e.) | % | (s.e.) | % | (s.e.) | % | (s.e.) | (n) | |
| I. Low/Middle Income | |||||||||||
| Brazil – São Paulo | 18.0 | (0.8) | 50.0 | (2.2) | 10.1 | (0.6) | 51.2 | (2.9) | 39.9 | (2.8) | (2942) |
| Bulgaria | 6.7 | (0.5) | 32.5 | (3.3) | 3.0 | (0.3) | 37.8 | (5.0) | 36.7 | (4.9) | (2233) |
| Colombia | 11.8 | (0.7) | 50.4 | (3.0) | 5.3 | (0.5) | 63.8 | (4.1) | 50.7 | (4.4) | (2381) |
| Columbia – Medellin | 9.9 | (0.7) | 51.4 | (3.6) | 3.8 | (0.4) | 54.0 | (5.2) | 47.3 | (5.1) | (1673) |
| Iraq | 7.2 | (0.6) | 46.1 | (4.2) | 3.9 | (0.4) | 50.7 | (5.8) | 42.1 | (5.7) | (4332) |
| Lebanon | 10.3 | (0.8) | 44.7 | (3.6) | 4.9 | (0.5) | 43.6 | (5.3) | 35.1 | (5.0) | (1031) |
| Mexico | 7.6 | (0.5) | 46.5 | (2.9) | 3.7 | (0.3) | 59.4 | (3.9) | 46.0 | (4.1) | (2362) |
| Nigeria | 3.2 | (0.3) | 19.1 | (3.5) | 1.1 | (0.2) | 20.3 | (5.9) | 18.7 | (5.8) | (2143) |
| Peru | 6.4 | (0.4) | 35.9 | (3.3) | 2.7 | (0.3) | 49.5 | (5.4) | 37.2 | (5.1) | (1801) |
| PRCb – Beijing/Shanghai | 3.8 | (0.4) | 25.3 | (6.0) | 2.0 | (0.3) | 36.8 | (9.5) | 33.6 | (9.7) | (1628) |
| PRCb – Shenzhen | 6.8 | (0.6) | 18.7 | (3.4) | 3.6 | (0.4) | 22.0 | (3.8) | 16.2 | (3.4) | (2475) |
| Romania | 2.9 | (0.4) | 27.0 | (5.7) | 1.5 | (0.3) | 31.5 | (8.8) | 25.9 | (8.4) | (2357) |
| Total | 8.1 | (0.2) | 42.4 | (1.1) | 4.0 | (0.1) | 48.0 | (1.6) | 38.8 | (1.5) | (27 358) |
| II. High Income | |||||||||||
| Australia | 12.8 | (0.5) | 51.4 | (2.1) | 4.8 | (0.3) | 59.0 | (3.5) | 49.0 | (3.4) | (8841) |
| Belgium | 14.1 | (1.1) | 29.8 | (3.3) | 5.2 | (0.7) | 37.7 | (6.3) | 29.9 | (5.6) | (1043) |
| France | 20.4 | (1.2) | 41.6 | (2.6) | 5.6 | (0.6) | 51.0 | (5.3) | 41.8 | (5.3) | (1436) |
| Germany | 10.3 | (0.7) | 45.0 | (3.1) | 3.1 | (0.4) | 57.9 | (5.6) | 48.7 | (5.7) | (1323) |
| Israel | 9.8 | (0.4) | 21.9 | (2.0) | 5.9 | (0.4) | 23.7 | (2.7) | 18.1 | (2.4) | (4859) |
| Italy | 9.7 | (0.5) | 39.3 | (2.6) | 2.9 | (0.3) | 46.2 | (5.1) | 41.3 | (5.0) | (1779) |
| Japan | 6.8 | (0.5) | 27.6 | (3.5) | 2.4 | (0.3) | 42.2 | (6.7) | 29.1 | (5.9) | (1682) |
| Netherlands | 18.0 | (1.3) | 40.6 | (3.3) | 4.9 | (0.7) | 49.3 | (6.6) | 32.5 | (5.9) | (1094) |
| New Zealand | 15.8 | (0.5) | 52.4 | (1.4) | 5.7 | (0.3) | 60.3 | (2.4) | 49.5 | (2.4) | (7312) |
| Northern Ireland | 17.7 | (1.0) | 56.8 | (2.8) | 8.8 | (0.7) | 61.4 | (4.4) | 47.2 | (4.3) | (1986) |
| Poland | 3.8 | (0.3) | 32.2 | (3.6) | 1.6 | (0.2) | 36.7 | (5.1) | 27.8 | (4.6) | (4000) |
| Portugal | 17.4 | (0.8) | 45.3 | (2.1) | 7.0 | (0.5) | 49.8 | (3.3) | 42.5 | (3.3) | (2060) |
| Spain | 10.4 | (0.6) | 34.9 | (2.6) | 3.8 | (0.3) | 48.4 | (4.5) | 40.0 | (4.3) | (2121) |
| Spain – Murcia | 15.3 | (1.0) | 32.0 | (3.0) | 6.9 | (0.7) | 36.7 | (4.8) | 23.2 | (3.8) | (1459) |
| US | 16.6 | (0.5) | 62.6 | (1.4) | 6.7 | (0.3) | 71.9 | (1.9) | 58.5 | (2.2) | (5692) |
| Total | 13.0 | (0.2) | 46.9 | (0.7) | 5.1 | (0.1) | 53.3 | (1.1) | 42.9 | (1.1) | (46 687) |
| III. Total | 11.2 | (0.1) | 45.7 | (0.6) | 4.7 | (0.1) | 51.7 | (0.9) | 41.6 | (0.9) | (74 045) |
aAnxiety disorders include generalised anxiety disorder, panic disorder with or without agoraphobia, agoraphobia without a history of panic disorder, specific phobia, social phobia, separation anxiety and post-traumatic stress disorder.
bPeople's Republic of China.